HJ Research delivers in-depth insights on the global Genomics market in its upcoming report titled, Global Genomics Market Report 2018-2029. According to this study, the global Genomics market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Genomics market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Genomics market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Genomics industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Genomics industry.
Global Genomics market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Genomics industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Genomics market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Genomics. The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Genomics market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Genomics in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Genomics market include:
Illumina Inc
Agilent Technologies
Roche Diagnostics
Cancer Genetics Inc
Bio-Rad Laboratories
Sigma Aldrich
Qiagen
Perkin Elmer
Affymetrix
GE Healthcare
Market segmentation, by product types:
Instruments
Consumables
Services
Market segmentation, by applications:
Hospitals
Research Institutes
Others
1 Industry Overview of Genomics
1.1 Research Scope
1.2 Market Segmentation by Types of Genomics
1.3 Market Segmentation by End Users of Genomics
1.4 Market Dynamics Analysis of Genomics
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Genomics Industry
2.1 Illumina Inc
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Genomics Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Agilent Technologies
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Genomics Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Roche Diagnostics
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Genomics Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Cancer Genetics Inc
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Genomics Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 Bio-Rad Laboratories
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Genomics Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 Sigma Aldrich
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Genomics Revenue and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 Qiagen
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Genomics Revenue and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 Perkin Elmer
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Genomics Revenue and Gross Margin (2018-2023)
2.8.4 Contact Information
2.9 Affymetrix
2.9.1 Company Overview
2.9.2 Main Products and Specifications
2.9.3 Genomics Revenue and Gross Margin (2018-2023)
2.9.4 Contact Information
2.10 GE Healthcare
2.10.1 Company Overview
2.10.2 Main Products and Specifications
2.10.3 Genomics Revenue and Gross Margin (2018-2023)
2.10.4 Contact Information
3 Global Genomics Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Genomics by Regions (2018-2023)
3.2 Global Sales Revenue of Genomics by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Genomics by Types (2018-2023)
3.4 Global Sales Revenue of Genomics by End Users (2018-2023)
4 Northern America Genomics Market Analysis by Countries, Types and End Users
4.1 Northern America Genomics Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Genomics Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Genomics Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Genomics Sales Revenue Analysis (2018-2023)
4.5 Canada Genomics Sales Revenue Analysis (2018-2023)
5 Europe Genomics Market Analysis by Countries, Types and End Users
5.1 Europe Genomics Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Genomics Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Genomics Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Genomics Sales Revenue Analysis (2018-2023)
5.5 France Genomics Sales Revenue Analysis (2018-2023)
5.6 UK Genomics Sales Revenue Analysis (2018-2023)
5.7 Italy Genomics Sales Revenue Analysis (2018-2023)
5.8 Russia Genomics Sales Revenue Analysis (2018-2023)
5.9 Spain Genomics Sales Revenue Analysis (2018-2023)
5.10 Netherlands Genomics Sales Revenue Analysis (2018-2023)
6 Asia Pacific Genomics Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Genomics Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Genomics Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Genomics Sales Revenue Analysis by End Users (2018-2023)
6.4 China Genomics Sales Revenue Analysis (2018-2023)
6.5 Japan Genomics Sales Revenue Analysis (2018-2023)
6.6 Korea Genomics Sales Revenue Analysis (2018-2023)
6.7 India Genomics Sales Revenue Analysis (2018-2023)
6.8 Australia Genomics Sales Revenue Analysis (2018-2023)
6.9 Indonesia Genomics Sales Revenue Analysis (2018-2023)
6.10 Vietnam Genomics Sales Revenue Analysis (2018-2023)
7 Latin America Genomics Market Analysis by Countries, Types and End Users
7.1 Latin America Genomics Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Genomics Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Genomics Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Genomics Sales Revenue Analysis (2018-2023)
7.5 Mexico Genomics Sales Revenue Analysis (2018-2023)
7.6 Argentina Genomics Sales Revenue Analysis (2018-2023)
7.7 Colombia Genomics Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Genomics Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Genomics Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Genomics Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Genomics Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Genomics Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Genomics Sales Revenue Analysis (2018-2023)
8.6 South Africa Genomics Sales Revenue Analysis (2018-2023)
8.7 Egypt Genomics Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Genomics Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Genomics by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Genomics by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Genomics by End Users (2024-2029)
10.4 Global Revenue Forecast of Genomics by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Genomics
11.1 Upstream Analysis of Genomics
11.2 Downstream Major Consumers Analysis of Genomics
11.3 Major Suppliers of Genomics with Contact Information
11.4 Supply Chain Relationship Analysis of Genomics
12 Genomics New Project Investment Feasibility Analysis
12.1 Genomics New Project SWOT Analysis
12.2 Genomics New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Genomics Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Genomics
Table End Users of Genomics
Figure Market Drivers Analysis of Genomics
Figure Market Challenges Analysis of Genomics
Figure Market Opportunities Analysis of Genomics
Table Market Drivers Analysis of Genomics
Table Illumina Inc Information List
Figure Genomics Specifications of Illumina Inc
Table Genomics Revenue (Million USD) and Gross Margin of Illumina Inc (2018-2023)
Figure Genomics Revenue (Million USD) and Global Market Share of Illumina Inc (2018-2023)
Table Agilent Technologies Information List
Figure Genomics Specifications of Agilent Technologies
Table Genomics Revenue (Million USD) and Gross Margin of Agilent Technologies (2018-2023)
Figure Genomics Revenue (Million USD) and Global Market Share of Agilent Technologies (2018-2023)
Table Roche Diagnostics Information List
Figure Genomics Specifications of Roche Diagnostics
Table Genomics Revenue (Million USD) and Gross Margin of Roche Diagnostics (2018-2023)
Figure Genomics Revenue (Million USD) and Global Market Share of Roche Diagnostics (2018-2023)
Table Cancer Genetics Inc Information List
Figure Genomics Specifications of Cancer Genetics Inc
Table Genomics Revenue (Million USD) and Gross Margin of Cancer Genetics Inc (2018-2023)
Figure Genomics Revenue (Million USD) and Global Market Share of Cancer Genetics Inc (2018-2023)
Table Bio-Rad Laboratories Information List
Figure Genomics Specifications of Bio-Rad Laboratories
Table Genomics Revenue (Million USD) and Gross Margin of Bio-Rad Laboratories (2018-2023)
Figure Genomics Revenue (Million USD) and Global Market Share of Bio-Rad Laboratories (2018-2023)
Table Sigma Aldrich Information List
Figure Genomics Specifications of Sigma Aldrich
Table Genomics Revenue (Million USD) and Gross Margin of Sigma Aldrich (2018-2023)
Figure Genomics Revenue (Million USD) and Global Market Share of Sigma Aldrich (2018-2023)
Table Qiagen Information List
Figure Genomics Specifications of Qiagen
Table Genomics Revenue (Million USD) and Gross Margin of Qiagen (2018-2023)
Figure Genomics Revenue (Million USD) and Global Market Share of Qiagen (2018-2023)
Table Perkin Elmer Information List
Figure Genomics Specifications of Perkin Elmer
Table Genomics Revenue (Million USD) and Gross Margin of Perkin Elmer (2018-2023)
Figure Genomics Revenue (Million USD) and Global Market Share of Perkin Elmer (2018-2023)
Table Affymetrix Information List
Figure Genomics Specifications of Affymetrix
Table Genomics Revenue (Million USD) and Gross Margin of Affymetrix (2018-2023)
Figure Genomics Revenue (Million USD) and Global Market Share of Affymetrix (2018-2023)
Table GE Healthcare Information List
Figure Genomics Specifications of GE Healthcare
Table Genomics Revenue (Million USD) and Gross Margin of GE Healthcare (2018-2023)
Figure Genomics Revenue (Million USD) and Global Market Share of GE Healthcare (2018-2023)
Table Global Revenue (Million USD) of Genomics by Regions (2018-2023)
Table Global Revenue (Million USD) of Genomics by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Genomics by Types (2018-2023)
Table Global Revenue (Million USD) of Genomics by End Users (2018-2023)
Table Northern America Genomics Revenue (Million USD) by Countries (2018-2023)
Table Northern America Genomics Revenue (Million USD) by Types (2018-2023)
Table Northern America Genomics Revenue (Million USD) by End Users (2018-2023)
Figure United States Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Genomics Revenue (Million USD) by Countries (2018-2023)
Table Europe Genomics Revenue (Million USD) by Types (2018-2023)
Table Europe Genomics Revenue (Million USD) by End Users (2018-2023)
Figure Germany Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Genomics Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Genomics Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Genomics Revenue (Million USD) by End Users (2018-2023)
Figure China Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Genomics Revenue (Million USD) by Countries (2018-2023)
Table Latin America Genomics Revenue (Million USD) by Types (2018-2023)
Table Latin America Genomics Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Genomics Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Genomics Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Genomics Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Genomics Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Genomics by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Genomics by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Genomics by End Users (2024-2029)
Table Major Consumers with Contact Information of Genomics
Table Major Suppliers of Genomics with Contact Information
Figure Supply Chain Relationship Analysis of Genomics
Table New Project SWOT Analysis of Genomics
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Genomics
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Genomics Industry
Table Part of References List of Genomics Industry
Table Units of Measurement List
Table Part of Author Details List of Genomics Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Genomics industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Genomics market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Genomics manufacturers, Genomics raw material suppliers, Genomics distributors as well as buyers. The primary sources from the supply side include Genomics manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Genomics raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Genomics industry landscape and trends, Genomics market dynamics and key issues, Genomics technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Genomics competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Genomics market size and forecast by regions, Genomics market size and forecast by application, Genomics market size and forecast by types, Genomics company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
